Expect Equity LLC Makes New Investment in The Cooper Companies, Inc. $COO

Expect Equity LLC bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the second quarter, Holdings Channel.com reports. The fund bought 42,050 shares of the medical device company’s stock, valued at approximately $3,015,000. Cooper Companies accounts for approximately 1.9% of Expect Equity LLC’s portfolio, making the stock its 19th biggest holding.

Other institutional investors and hedge funds have also made changes to their positions in the company. Legal & General Group Plc purchased a new stake in shares of Cooper Companies in the 2nd quarter valued at about $60,521,000. The Manufacturers Life Insurance Company purchased a new position in Cooper Companies during the 2nd quarter worth approximately $69,129,000. Sone Capital Management LLC acquired a new position in Cooper Companies during the second quarter worth approximately $27,754,000. Trajan Wealth LLC acquired a new position in Cooper Companies during the second quarter worth approximately $19,348,000. Finally, Manning & Napier Advisors LLC purchased a new stake in Cooper Companies in the second quarter valued at approximately $107,939,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Down 3.6%

Shares of Cooper Companies stock opened at $73.04 on Wednesday. The company has a market cap of $14.24 billion, a P/E ratio of 61.90, a PEG ratio of 1.98 and a beta of 0.83. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83. The firm has a fifty day moving average of $72.20 and a two-hundred day moving average of $71.01.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business’s revenue was up 7.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the company. Mizuho set a $85.00 price objective on Cooper Companies and gave the company an “outperform” rating in a report on Thursday, June 4th. BNP Paribas Exane cut their target price on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a report on Monday, June 8th. Citigroup reiterated a “neutral” rating and issued a $80.00 price target (up from $76.00) on shares of Cooper Companies in a research report on Thursday, August 13th. Stifel Nicolaus lowered their price objective on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. Finally, Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research note on Sunday, June 21st. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Cooper Companies currently has an average rating of “Hold” and a consensus price target of $81.64.

Cooper Companies News Roundup

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Traders purchased 4,056 call options on COO, roughly 411% above the typical daily volume of 794 contracts. This points to increased speculative bullish interest, although options activity alone does not guarantee a sustained stock advance.
• Neutral Sentiment: The latest short-interest report lists zero shares sold short and a 0.0-day short-interest ratio, but it also describes the change as “NaN” from a prior total of zero. The figures appear inconsistent and provide little useful information about investor positioning. Short Interest Report
• Negative Sentiment: COO’s valuation remains demanding, with a reported P/E ratio near 62. That can make the shares more sensitive to profit-taking or a lack of fresh positive catalysts, even though the company recently exceeded quarterly earnings and revenue expectations and reported year-over-year revenue growth.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.